SPOTLIGHT -
Rochester, NY-Bausch & Lomb has made an equity investment in-and secured an exclusive option to purchase-AcuFocus Inc., a developer of corneal inlay technology for treating presbyopia.
Bausch + Lomb announces results from a clinical study of a novel daily nutritional supplement for dry eyes
(EyePod) From idea to impact: Navigating ophthalmic innovation
The Fred Hollows Foundation supporting 2030 IN SIGHT LIVE
EyePod: Modifier Gene Therapy: What is it?
Verana Health launches its Qdata Thyroid Eye Disease module
Gene editing untangles one strand of the AMD web